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Background: Isolated atherosclerotic middle cerebral artery (MCA) disease is often difficult to differentiate
from cardioembolic disease if intracranial atherosclerosis coexists with cardiac disease.
Objectives: To evaluate whether clinical and neuroradiological features of isolated MCA disease differ
according to the underlying aetiology.
Methods: Isolated MCA disease was defined as a unilateral angiographically occlusive lesion of the MCA
on the symptomatic side without lesions of other intracranial or extracranial vessels. Patients with isolated
MCA disease were divided into atherosclerotic and potentially cardioembolic, and the clinical, laboratory,
and neuroradiological data analysed.
Results: Among the 850 consecutive patients with acute ischaemic stroke or transient ischaemic attack,
107 (12.6%) met the criteria for isolated MCA disease (76 with atherosclerotic disease and 31 with a
potential source of cardiac embolism). Total anterior circulation infarcts were more common and baseline
NIHSS score was higher in potentially embolic occlusions than in atherosclerotic disease (each p,0.001).
While cortical infarcts and territorial infarcts were more common in the potential embolism group
(p = 0.028 and p,0.001, respectively), subcortical border zone infarcts were more common in the
atherosclerotic group (p,0.001). Multiple regression analysis showed that border zone infarcts and mild
stroke were independently associated with atherosclerotic MCA disease, while territorial and cortical
infarcts were associated with potential cardiac embolic disease.
Conclusions: Clinical and neuroradiological characteristics can differentiate isolated atherosclerotic MCA
disease from MCA disease associated with potential sources of cardiac embolism, and may reflect the
differences in underlying pathogenesis.
I
solated atherosclerotic lesions in large intracranial arteries,
especially the middle cerebral artery (MCA), have been
considered rare causes of ischaemic stroke in the white
population; however, previous studies have shown that they
are common in Asians.1–5 Atherosclerotic MCA disease
presents morphologically as stenosis or occlusion on angio-
graphy, and can mimic embolic MCA lesions from either the
heart or the internal carotid artery. In unselected series,
about one third of the cases of MCA occlusion are attributed
to emboli from the heart.5 6 The fate of embolic MCA
occlusions can be varied.7 8 Although the rate of spontaneous
recanalisation is dependent on the character of the embolus
and may reflect differences in study design,9 most embolic
occlusions recanalise completely. Thus, if repeat angiography
shows that an MCA lesion has resolved a diagnosis of
embolism could be inferred, but if there is permanent
occlusion or partial recanalisation it is difficult to differenti-
ate an embolic lesion from in situ thrombotic lesions such as
thrombotic occlusion or incompletely developed atheroma.10
Furthermore, in situations where recanalisation has not yet
fully occurred, especially when seen for the first time or when
intracranial atherosclerosis coexists with cardiac disease, the
distinction between cardioembolic and atherosclerotic MCA
disease is more difficult.
In contrast to cardioembolic MCA disease, the pathogen-
esis of atherosclerotic MCA disease includes thrombosis
leading to complete occlusion, thromboembolism, haemo-
dynamic compromise, or combinations of these factors.5 11
Assuming that the differing pathogenesis of MCA disease
may be reflected in specific clinical and neuroradiological
features, we have studied a consecutive series of patients
with isolated MCA disease to determine whether athero-
sclerotic MCA disease can be distinguished by such features
from isolated MCA disease accompanied by clinical evidence
of cardioembolism.
METHODS
From September 2000 to May 2003, we studied retro-
spectively consecutive patients with isolated MCA disease
who were admitted to Ajou University hospital within seven
days of symptom onset. Isolated MCA disease was defined as
a unilateral MCA stenosis of .50% or occlusion on magnetic
resonance angiography (MRA) or transfemoral conventional
angiography (TFCA) without significant involvement of other
intracranial or extracranial arteries on the diagnostic workup.
The vascular neuroimaging workup consisted of TFCA, MRA
(with carotid bifurcation imaging), or MRA with carotid
Doppler. All patients underwent transthoracic echocardio-
graphy. Depending on whether there was clinical evidence of
cardiogenic embolism, we divided isolated MCA disease into
atherosclerotic disease and potentially cardioembolic disease.
Isolated MCA diseases accompanying contralateral hemi-
spheric or posterior circulation spotty lesions on diffusion
weighted imaging (DWI) were excluded. In contrast to the
description of cardioembolism used in the TOAST classifica-
tion,12 MCA disease with a potential source of cardiac
embolism in the present study included any subcortical
Abbreviations: CS, combined subcortical infarct; DP, deep perforator
infarct; DWI, diffusion weighted imaging; EB, external border zone; IB,
internal border zone; MCA, middle cerebral artery; MRA, magnetic
resonance angiography; NIHSS, National Institutes of Health stroke
scale; SP, superficial perforator infarct; TFCA, transfemoral conventional
angiography; TOAST, time resolved optical absorption and scattering
tomography
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infarcts regardless of their size or the clinical presentation of
lacunes. Potential sources of cardiogenic embolism were as
follows: recent myocardial infarction (less than three weeks
before), known atrial fibrillation with or without mural
thrombus, mitral stenosis or prosthetic valve, dilated cardio-
myopathy, sick sinus syndrome, and acute bacterial endo-
carditis. For the sake of an exact aetiological classification,
patients who did not have a full workup or those who had
two or more aetiologies were excluded from the study. We
also excluded patients with bilateral isolated MCA stenosis
exceeding 50% (n = 18).
Magnetic resonance imaging (MRI) was done within one
week of the onset of symptoms (mean 2.5 days; range 1 to 7).
We undertook a comparative analysis to determine whether
the clinical and radiological features of atherosclerotic MCA
disease could be distinguished from those of MCA disease
with a potential source of cardiac embolism.
We reviewed the medical history, neurological examination
findings, and laboratory test results. According to the clinical
stroke syndrome, we divided patients into lacunar, partial
anterior circulation, and total anterior circulation infarcts.13
The vascular risk factors were identified as follows:
N hypertension: use of antihypertensive agents, or systolic
blood pressure >160 mm Hg, or diastolic blood pressure
>95 mm Hg on admission;
N diabetes mellitus: use of oral hypoglycaemic agents or
glycosylated haemoglobin .6.4%;
N hypercholesterolaemia: use of antihyperlipidaemic agents
or serum cholesterol level .220 mg/dl;
N smoking: any cigarette usage within the 28 days preceding
the index stroke.
All patients underwent DWI. MRA was done on a 1.5 T
machine (GE, Signa, Advantage). The diagnosis of infarcts on
the MCA territory was made with the use of previously
published templates (fig 1).14–16 MCA lesions on DWI were
individually classified as subcortical, cortical (involvement of
only one M2 branch of MCA), and territorial infarcts
(involvement of more than one M2 branch of the MCA or
MCA stem involvement).7 According to the topographical
classification suggested by Bogousslavsky and Regli, sub-
cortical infarcts were further subdivided into deep perforator
(DP), border zone including either internal or external border
zone infarcts, superficial perforator (SP), and combined
subcortical (CS) infarcts.15 Using DWI, we also analysed
spotty lesions in the cortical region concomitantly.
Haemorrhagic transformation was assessed using baseline
computed tomography (CT), with further CT or MRI within
one week after symptom onset. Any areas of heterogeneous
or homogeneous hypointense signal within the infarct area
on T2 weighted imaging or DWI, and heterogeneous or
homogeneous high signal on non-contrast CT were defined
as haemorrhagic transformation.17 18
In addition, we recruited patients with acute MCA infarcts
on DWI who had a potential source of cardioembolism
without an occlusive MCA lesion on MRA, to determine
whether the clinicoradiological features of MCA disease with
a potential source of cardiac embolism could be distinguished
from those of recanalised cardioembolic MCA infarcts. These
patients were selected from the same study pool of isolated
MCA disease and were defined as cases of potential
cardioembolism without MCA disease.
We measured M1 stenosis on MRA or TFCA by previously
suggested methods.19 The M1 stenosis was calculated
according to the residual lumen diameter measured at the
site of maximum narrowing and the diameter of the adjacent
normal vessel, from which the percentage stenosis was
calculated. The degree of stenosis was graded as follows: low
degree of stenosis (50–74%); high degree of stenosis (75–
99%); and occlusion. These measurements were made
independently by two of us (LPH and OSH), using a hand
held caliper; an acceptable level of interobserver agreement in
interpreting angiographic stenosis was observed (k= 0.853).
Because of poor visualisation of the lenticulostriatal artery on
MRA, the location of MCA disease was roughly divided into
proximal and distal halves of M1.
Statistics
Statistical analyses were undertaken using a commercially
available software package (SPSS, version 10.0). We used x2
and t tests to compare clinical features and stroke subtype
with respect to aetiology when the variables were categorical
and continuous, respectively. Variables were considered for
multivariate analysis if they had a probability (p) value of
(0.1 in univariate analysis. Logistic regression analysis
using the backward stepwise method was applied to look
for independent predictors of atherosclerotic MCA disease
and MCA occlusion with a potential source of cardiac
embolism. Independent variables were sex, age, risk factors,
mild stroke (NIHSS score20 ,6), severe stroke (NIHSS score
>6), stroke syndrome, and neuroradiological topography.
Results are given as odds ratios (OR) as estimates of relative
risk with 95% confidence intervals (CI). A p value of less than
0.05 was used to determine a statistically significant
difference.
RESULTS
Among the 850 consecutive patients with acute ischaemic
stroke or transient ischaemic attacks, 107 (12.6%) met the
criteria for isolated MCA disease. Among these 107 patients,
76 were classified as atherosclerotic and 31 as potentially
cardioembolic. Of the latter, 20 had atrial fibrillation, five had
valvar heart disease, three had recent myocardial infarction,
two had dilated cardiomyopathy, and one had sick sinus
syndrome. Details of the clinical features in the two groups
are given in table 1. Twelve patients with atherosclerotic
MCA disease (15.8%) and one with potentially cardioembolic
MCA disease (3.2%) presented with a clinical diagnosis of
transient ischaemic attacks (TIA).
Clinically, while total anterior circulation infarcts were
more common in the potential cardiac embolism group
(p,0.001), lacunar and partial anterior circulation infarcts
were more often observed in the atherosclerotic group
(p = 0.012 and 0.004, respectively). Patients with athero-
sclerotic MCA disease were younger (p = 0.006) and more
often had hypertension and diabetes (p = 0.024 and 0.038,
respectively) than patients with MCA disease with a potential
source of cardiac embolism. Serum triglyceride was higher in
the atherosclerotic group than in the potential embolism
group (mean (SD): 2.00 (1.92) v 1.15 (0.55) mmol/l,
p = 0.002). The degree of the initial neurological deficit,
defined as baseline NIHSS score, was more severe in the
potential embolism group than in the atherosclerotic group
(9.7 (4.7) v 4.6 (3.9), p,0.001). The potential embolism
group arrived more rapidly at hospital and more often
presented with a sudden onset of stroke than the
atherosclerotic group (p = 0.002 and 0.001, respectively).
No significant differences in sex, smoking, or other
laboratory data (initial glucose, total cholesterol, low
density lipoprotein cholesterol, high density lipoprotein
cholesterol, packed cell volume) were detected between
the two groups.
TFCA was done in 22 patients with atherosclerotic MCA
disease (five with low degree stenosis, 10 with high degree
stenosis, and seven with occlusion) and in three patients
with potentially cardioembolic MCA disease (all had MCA
occlusions). No patients with potentially cardioembolic MCA
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Figure 1 Definition of topographic patterns using diffusion weighted magnetic resonance imaging. Territorial infarcts (A) showing involvement of
more than one M2 branch of the middle cerebral artery (MCA), or MCA stem involvement and cortical infarcts (B), showing involvement of only one M2
branch of the MCA. Subcortical infarcts (C) are subdivided into deep perforator (DP) infarcts, border zone infarcts including either internal (IB) or
external border zone (EB) infarcts, and superficial perforator (SP) infarcts.
Table 1 Demographic features of patients with middle cerebral artery occlusions
Variable
AS-MCA
(n = 76) p Value
PSCE-MCA
(n = 31) p Value
PSCE without MCA
(n = 30)
Male sex 39 (52.0) NS 18 (58.1) NS 16 (53.3)
Age (years)* 58 (13) 0.006 66 (14) NS 64 (11)
Risk factors
Hypertension 51 (61.8) 0.024` 13 (43.3) NS 12 (40.0)
Diabetes 25 (33.3) 0.0381 4 (13.3) NS 5 (16.7)
Smoking 23 (35.9) NS 9 (30.0) NS 10 (33.3)
Blood glucose (mmol/l)* 8.73 (4.28) NS 8.51 (3.42) NS 8.73 (3.33)
Total serum cholesterol
(mmol/l)* 4.88 (1.10) NS 4.61 (1.07) NS 5.07 (1.48)
LDL (mmol/l)* 2.86 (0.92) NS 2.93 (0.87) NS 2.62 (0.99)
HDL (mg/dl)* 1.19 (0.29) NS 1.24 (0.24 NS 1.28 (0.33)
TG (mg/dl)* 2.00 (1.92) 0.002 1.15 (0.55) NS 1.28 (0.47)
PCV (%)* 39.8 (6.7) NS 40.3 (5.8) NS 41.6 (6.1)
Stroke syndrome
Lacuna 31 (48.4) 0.012` 6 (20.0) NS 2 (6.7)
Partial 25 (39.1) 0.0041 3 (10.0) ,0.0011 22 (73.3)
Total 8 (12.5) ,0.001` 21 (70.0) ,0.0011 5 (16.7)
Initial NIHSS score* 4.6 (3.9) ,0.001 9.7 (4.7) ,0.001 5.2 (3.6)
Time from onset to
hospital (h)* 35 (40) 0.002 14 (19) NS 23 (32)
Abrupt onset 37 (48.7) 0.001` 26 (83.8) NS 26 (86.6)
Site of MCA lesion 0.008`
Proximal 59 (77.6) 16 (51.6) – –
Distal 17 (22.4) 15 (48.4) – –
Degree of stenosis
Low degree 19 (25.0) NS 6 (19.4) – –
High degree 32 (32.1) NS 6 (19.4) – –
Occlusion 25 (32.9) 0.007` 19 (61.2) – –
Values are n (%) or *mean (SD).
AS-MCA, atherosclerotic middle cerebral artery disease; HDL, high density lipoprotein cholesterol; LDL, low density
lipoprotein cholesterol; MCA, middle cerebral artery disease; NIHSS, National Institutes of Health stroke scale;
Partial, partial anterior circulation infarct; PCV, packed cell volume; PSCE-MCA, middle cerebral artery disease
with potential source of cardioembolism; TG, triglycerides; Total, total anterior circulation infarct.
Mann–Whitney test, `Pearson x2 test, 1Fischer’s exact test.
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disease had collaterals from the posterior or anterior cerebral
artery, whereas 14 patients (63.6%) with atherosclerotic MCA
disease diseases had good collaterals on TFCA. Based on
angiographic characteristics, lesions of the MCA were more
proximally located in the atherosclerotic group than in the
potential embolism group (77.6% v 51.6%, p = 0.008) and
complete MCA occlusion was more common in the potential
embolism group than in the atherosclerotic group (61.2% v
32.9%, p = 0.007).
Excluding 12 patients with atherosclerotic MCA disease
who presented with TIA without fresh lesions on DWI, we
made a comparative analysis of radiological patterns between
patients with atherosclerotic MCA disease (n = 64) and
patients with potentially cardioembolic MCA disease
(n = 31) (table 2). Neuroradiologically, subcortical infarcts
were significantly more common in the atherosclerotic group
than in the potential embolism group (82.8% v 19.4%,
p,0.001). Individual analysis of subcortical infarcts showed
that border zone infarcts were more common in the
atherosclerotic group than in the potential embolism group
(p,0.001) and there was a trend for DP infarcts to be more
common in the atherosclerotic group (p = 0.049). The border
zone infarct group comprised 15 patients with internal border
zone infarcts, six with external border zone infarcts, and
three with combined internal and external border zone
infarcts. Cortical infarcts and territorial infarcts, however,
were significantly more common in MCA disease with a
potential source of cardiac embolism (p = 0.028 and p,0.001,
respectively). Cortical spotty lesions on DWI did not differ
between the two groups.
On multivariate logistic regression analysis, border zone
infarcts (OR 13.4 (95% CI, 1.5 to 118.3), p = 0.019) and mild
stroke (OR 9.2 (2.9 to 28.6)) were significant predictors of
atherosclerotic MCA disease, while territorial infarcts (OR
52.9 (2.2 to 138.8), p = 0.006) and cortical infarcts (OR 9.6
(2.4 to 38.0), p = 0.001) were independently associated with
potentially cardioembolic MCA disease. Though not reaching
statistical significance, DP infarcts (OR 3.8), cortical spotty
lesions (OR 3.4), and SP infarcts (OR 2.1) tended to be
associated with atherosclerotic MCA disease, and haemor-
rhagic transformation (OR 3.1) trend to be associated with
potentially cardioembolic MCA disease.
The topographic patterns are schematically illustrated in
fig 2 with respect to the degree of MCA stenosis. In MCA
occlusion, potentially cardioembolic MCA diseases were often
manifested by territorial infarcts, while atherosclerotic MCA
disease was associated with border zone infarcts (p,0.001).
In high degree stenosis, MCA disease with a potential source
of cardiac embolism were related to cortical infarcts more
often than atherosclerotic MCA disease (p = 0.04).
In a comparative analysis between the two groups of
patients with potential sources of cardiac embolism (with
and without occlusive MCA disease; tables 1 and 2), the
group with MCA disease was more likely to have total
anterior circulation infarcts and territorial infarcts (p,0.001
and p = 0.002, respectively), while the group without MCA
disease was more likely to have partial anterior circulation
infarcts and cortical infarcts (p,0.001 and p = 0.011,
respectively). Among the patients with potential sources of
cardiac embolism, the initial NIHSS score was higher in those
with MCA occlusive disease than in those without (9.7 (4.7) v
5.2 (3.6); p,0.001); haemorrhagic transformation was more
common in the group without MCA occlusive disease, but the
difference was not statistically significant. The average time
from onset of stroke to TFCA or MRA was not significantly
different between the two groups.
DISCUSSION
Studies on spontaneous recanalisation after cardioem-
bolic stroke show that, although most MCA occlusions
Table 2 Neuroradiological characteristics of patients with middle cerebral artery
occlusions
AS-MCA
(n = 64) p Value
PSCE-MCA
(n = 31) p Value
PSCE without
MCA (n = 30)
Subcortical infarct 53 (82.8) ,0.001 6 (19.4) NS 6 (20.0)
DP 15 (23.4) 0.049 2 (6.5) NS 1 (3.3)
Border zone 24 (37.5) ,0.001 1 (3.2) –
Internal border zone 18 (28.1) 0.005 1 (3.2)
External border zone 9 (14.1) 0.028 –
SP 13 (20.3) NS 2 (6.5) NS 5 (16.7)
CS (SP+DP) 5 (7.8) NS – –
Cortical infarct 8 (12.5) 0.028 10 (32.3) 0.011 20 (66.7)
Territorial infarct 3 (4.7) ,0.001 15 (48.4) 0.002 4 (13.3)
Cortical spotty lesion 22 (34.4) NS 5 (16.1) NS –
Haemorrhagic transformation 1 (1.5) NS 3 (9.7) NS 5 (16.7)
Values are n (%).
Together with internal border zone infarct (3), combined subcortical infarct (3), and superficial perforator infarct
(1).
Fischer’s exact test.
AS-MCA, atherosclerotic middle cerebral artery disease; CS, combined subcortical infarct; DP, deep perforator
infarct; MCA, middle cerebral artery disease; PSCE-MCA, middle cerebral artery disease with potential source of
cardioembolism; SP, superficial perforator infarct.
Figure 2 Differences in topography between atherosclerotic middle
cerebral artery (MCA) disease and MCA disease with potential sources
of cardioembolism, related to the degree of stenosis. AS, atherosclerotic
MCA disease; PSCE, MCA disease with a potential source of
cardioembolism.
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recanalise spontaneously in the first days, up to 30% remain
occluded even up to seven days after the event.7 8 However, it
is known that angiographic characteristics are unreliable in
distinguishing between atherosclerotic and cardioembolic
MCA lesions.10 In present study, about a half the patients
with presumed cardioembolic infarcts in the MCA territory
showed either MCA stenosis or occlusion on angiography,
which mimicked the lesions of atherosclerotic MCA disease.
As well as describing the vascular characteristics of sponta-
neous recanalisation, our study focused on certain clinical
and neuroradiological characteristics that were helpful in
differentiating between atherosclerotic and cardioembolic
MCA disease.
Clinically, patients with potentially cardioembolic MCA
disease were likely to have total anterior circulation infarcts,
and to have a higher baseline NIHSS score than patients with
atherosclerotic MCA disease. On the other hand, the
atherosclerotic group presented with mild neurological
deficits, such as lacunes or partial anterior circulation
infarcts. This difference in neurological deficits between the
two groups may explain the more rapid arrival in hospital of
patients with potentially cardioembolic MCA disease. The
increased prevalence of atrial fibrillation with age may
account for the older mean age of patients with potentially
cardioembolic MCA disease. On the basis of the topographic
patterns, the atherosclerotic group was more likely to present
with subcortical infarcts, while the potentially cardioembolic
group was more likely to present with cortical or territorial
infarcts, which were well correlated with the clinical
presentation. These clinical and topographical features could
be ascribed to differences in the adequacy of collateral
perfusion between the two groups.21 There may be well
developed collaterals in pre-existing and long standing
atherosclerotic MCA disease, whereas collaterals tend to be
inadequate in MCA occlusion caused by embolic disease.
In subgroup analysis of subcortical infarcts, although DP
infarcts were often associated with atherosclerotic MCA
disease—in accordance with our previous report that around
40% of deep striatocapsular infarcts were associated with
atherosclerotic MCA disease22—border zone infarcts were the
sole independent predictor of atherosclerotic MCA disease on
multivariate analysis. Internal border zone (IB) infarcts
accounted for about 75% of patients with border zone
infarcts in the present study. In previous studies it was
found that patients with IB infarcts had a higher frequency of
severe carotid artery stenosis or occlusion,23 24 and a
haemodynamic aetiology was suggested; this is indirectly
supported by PET and SPECT studies.25 26 Angeloni et al
reported that IB infarcts may result from isolated MCA
occlusions,27 and our data show that IB infarcts can result
from isolated atherosclerotic MCA disease without carotid
artery stenosis or occlusion. IB infarcts may serve as a
neuroradiological clue to differentiate isolated atherosclerotic
MCA disease from potentially embolic MCA disease. On the
other hand, the incidence of SP infarcts located in the most
superficial part of the corona radiata and the long association
fasciculi28 29 did not differ between the two groups. Although
the mechanism of SP infarcts is not settled, Yonemura et al
recently suggested that these infarcts are associated with
both emboligenic heart disease and large artery disease,30
which explains why there was no difference in SP infarcts
between the two groups in our study. This is further
supported by the finding that the incidence of cortical spotty
lesion detectable by DWI—known to be small embolic signals
either from large arteries or the heart31—did not differ
between the two groups.
On angiography, MCA lesions in the atherosclerotic group
were located in the more proximal part of the artery, reflec-
ting the similar mechanism in extracranial atherosclerosis,
where the lesions are frequently observed in regions of
arterial bifurcation. In our comparison between the degree of
stenosis and neuroradiological topography, MCA occlusion or
high degree stenosis had different clinical manifestation
depending on the pathogenesis (fig 2); the atherosclerotic
group often presented with border zone infarcts, whereas the
potentially cardioembolic group mainly presented with
cortical or territorial infarcts. These findings are in agreement
with previous reports emphasising the importance of
collateral circulatory pathways and collateral perfusion in
determining infarct pattern and size.7 27 32 33 In our compar-
ison of patients with potential sources of cardiogenic emboli
who did and did not have occlusive MCA disease, the pattern
of cortical involvement was similar in the two groups,
suggesting that they shared the common underlying patho-
genesis of cardioembolism; however, the patients with
occlusive MCA disease had more severe neurological deficits
and a radiologically more extensive infarct area, in agreement
with previous reports that early recanalisation of embolic
MCA occlusions has a favourable impact on infarct size and
clinical outcome.7 8
The differentiation between cardioembolic and athero-
sclerotic MCA disease may have clinical implications for early
anticoagulant treatment in cardioembolic stroke. Although
this subject remains under debate, it is known that recurrent
cardioembolic strokes mostly occur in the early stage after
infarction.34 However, the mechanism of atherosclerotic MCA
disease is known to be related to thromboembolism or
haemodynamic compromise, and thus an individual strategy
is required depending on the pathogenesis.
It may be unwise to extrapolate our findings relating to
MCA disease associated with a potential source of cardiac
embolism to definite cardioembolic MCA disease without
acquiring data from repeated vascular neuroimaging. This
reflects the controversy over cardiogenic embolism as a cause
of subcortical infarcts. Despite the fact that the association of
DP infarcts with cardioembolism is still under debate,35–38
recent reports suggest that the embolic contribution to the
pathogenesis of border zone and SP infarcts is more common
than expected.30 39 Furthermore, in our study one patient with
potentially cardioembolic MCA disease who had DP infarcts
showed complete recanalisation of the MCA at follow up
angiography, suggesting a cardioembolic mechanism. To
resolve this issue, further study with follow up vascular
neuroimaging is warranted.
Conclusions
In this study, infarcts caused by underlying haemodynamic
compromise were related to atherosclerotic middle cerebral
artery disease, while tandem artery infarcts caused by large
emboli were more common when there was MCA disease
with potential sources of cardioembolism. Our study also
suggests that the clinical and neuroradiological character-
istics of the cerebral lesions reflect the differences in
underlying pathogenesis, and are helpful in differentiating
between isolated atherosclerotic MCA disease and MCA
disease with a potential source of cardiac embolism.
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